8-K
filed February 6, 2026, 6:59 PM ET
ticker BCAB
CIK 0001826892
regulatory
confidence high
sentiment negative
materiality 0.90
BioAtla receives Nasdaq delisting notice; trading suspension effective Feb 10
BioAtla, Inc.
- Nasdaq Hearings Panel determined to suspend BCAB common stock at open on Feb 10, 2026 for non-compliance with $1.00 bid price and $2.5M stockholders' equity requirements.
- Company requested immediate review and stay by Listing Council; Nasdaq counsel refused, but company claims precedent exists for such stays.
- If suspended, BCAB is expected to trade on OTC under same symbol, which may materially affect trading price and volume.
- As of Feb 6, $1.25M principal remained outstanding under Pre-Paid Advance Agreements; SEPA prohibits share sales during suspension.
- Company asserts Nasdaq improperly delayed compliance confirmation and secretly overturned long-standing reverse stock split policy.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-041367
- form_type
- 8-K
- ticker
- BCAB
- cik
- 0001826892
- company_name
- BioAtla, Inc.
- filed_at
- 2026-02-06T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.390894+00:00
- generated_at
- 2026-05-16T04:07:53.344307+00:00
- sec_items
- ["3.01", "7.01"]
- event_type
- regulatory
- sentiment
- negative
- materiality_score
- 0.9
- calibrated_materiality_score
- 0.9
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-041367
- json_url
- https://secwatch.observer/filing/0001193125-26-041367.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-041367.md
- text_url
- https://secwatch.observer/filing/0001193125-26-041367.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1826892/000119312526041367/0001193125-26-041367-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1826892/000119312526041367/bcab-20260206.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
VSTD
Vestand receives Nasdaq delisting notice for late quarterly and annual filings
Vestand Inc.
May 26, 2026, 5:18 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
May 19, 2026, the Company received a Staff Delisting Determination letter (the “Staff Determination”) from Nasdaq notifying
it that Nasdaq has initiated a process which could result in the delisting of the Company’s secu
Filing page
SEC filing
AGAE
AGAE receives Nasdaq delisting notice over bid price <$1.00 and late 10-K; will appeal
Allied Gaming & Entertainment Inc.
May 11, 2026, 5:09 PM ET
regulatory
Items 3.01, 5.03, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
termination
before an independent Hearings Panel (the “Panel”) by May 13, 2026. On November 4, 2025, Staff notified the Company
that the bid price of the Common Stock had closed at less than $1.00 per share over 30 consecutive business days, and, as a result, did
not comply with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Staff Determination was issued pursuant
to Nasdaq Listing Rule 5810(c)(3)(A) on the grounds that the Company has not regained compliance with the Minimum Bid Price Rule during
a 180-day compliance period and is not eligible for a second 180-day complian
Filing page
SEC filing
SBEV
Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M
SPLASH BEVERAGE GROUP, INC.
May 5, 2026, 7:59 PM ET
regulatory
Items 1.01, 1.02, 3.01, 3.02, 5.03, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”)
that the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined
in Section 1
Filing page
SEC filing
VSTD
Vestand receives Nasdaq delisting notice for late 10-K filing; may submit compliance plan by May 18, 2026
Vestand Inc.
April 29, 2026, 7:59 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
April 23, 2026, Vestand Inc. (the “Company”) received a staff deficiency notice (the “Notice”) from The Nasdaq
Stock Market (“Nasdaq”) indicating that, because Nasdaq has not yet received the Company’s Form 10-K for the
Filing page
SEC filing
EDBL
Edible Garden receives Nasdaq delisting notice for bid price non-compliance; intends to appeal
Edible Garden AG Inc
May 29, 2026, 5:00 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
May 27, 2026, Edible Garden AG Incorporated (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for at least 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share (the “Bid Price Rule”). Under Nasdaq Listing Rule 5810(c)(3)(A)(iv), because the Company has effected a reverse stock split over the prior one-year per
Filing page
SEC filing
ONFO
Onfolio receives Nasdaq delisting notice for insufficient equity ($1.22M vs $2.5M min)
Onfolio Holdings, Inc
May 29, 2026, 4:30 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice
Filing page
SEC filing
LVLU
Lulu's Fashion Lounge gets Nasdaq delisting notice for negative stockholders' equity
Lulu's Fashion Lounge Holdings, Inc.
May 28, 2026, 4:01 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
May 21, 2026, Lulu’s Fashion Lounge Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is out of compliance with the minimum of $2.5 million of stockholders’ equity required for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1). The Company’s stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 29, 2026 was approximately $(525) thousand. The Company does not meet the a
Filing page
SEC filing
SONM
DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider
DNA X, Inc.
May 27, 2026, 4:35 PM ET
regulatory
Items 1.01, 2.03, 3.01, 3.02, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
February 6, 2026, BioAtla, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to suspend the Company’s securities from Nasdaq (the “Delist Determination”) based upon (i) the Company’s non-compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2) and (ii) the Company’s failure to demonstrate compliance with the $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1), the latter notwithstanding the Company’s prior compliance with the alterna
Comparable filing
May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests
a hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.